changing from semaglutide to tirzepatide Early Dose Escalation of after Switching in Type 2 Diabetes Mellitus Semaglutide to Tirzepatide: Switching Guide

Semaglutide, an injectable medication taken once a week, offers a nonsurgical way to reduce weight and treat obesity

For women in this demographic, the discussion with a healthcare provider should include: current bone density baseline (DXA if not recently done), adequacy of protein and calcium intake on a GLP-1-suppressed appetite, and whether a structured supplementation protocol - including collagen peptides as part of an overall protein strategy - is appropriate to layer in alongside resistance exercise and adequate vitamin D

Tirzepatide targets both GLP-1 and GIP receptors and boosts their effect on stomach emptying and insulin production

30 g: particularly suitable for those with higher energy requirements, such as athletes or people with a high calorie expenditure

This can provide a psychological boost, enhance motivation, and in many cases, make exercise easier